What is NDC 27808-090?

27808-090 is the product NDC for Dextroamphetamine Sulfate, Dextroamphetamine sulfate 10 mg/1 tablet, listed with the FDA by Cranbury Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Cranbury Pharmaceuticals, LLC, NDC labeler code 27808. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dextroamphetamine Sulfate?

38 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dextroamphetamine Sulfate NDC 27808-090

NDC codes

FDA NDC Directory

Product NDC (as listed)27808-090Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27808-0090Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27808-090-01	2780800900127808009001	100 TABLET in 1 BOTTLE, PLASTIC (27808-090-01)Marketed from Feb 28, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextroamphetamine Sulfate
Generic name (nonproprietary): dextroamphetamine sulfate
Active ingredients: Dextroamphetamine sulfate — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cranbury Pharmaceuticals, LLCNDC labeler code 27808
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206095
Marketing start: Aug 20, 2022
Listing expires: Dec 31, 2026
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 27808-090_97577638-7333-40a8-87d8-f426b7ee7672SPL ID 97577638-7333-40a8-87d8-f426b7ee7672SPL set ID 9acdf000-fefe-47c7-a44c-0f7a65c5c05cRxCUI 884385, 884386UNII JJ768O327N
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427808009001 followed by a unit qualifier and the quantity

Package 27808-0090-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 19, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dextroamphetamine Sulfate Tablets, USP are indicated for: Narcolepsy. Attention Deficit Disorder with Hyperactivity , as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 to 16 years) with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27808-090

What is NDC 27808-090?: 27808-090 is the product NDC for Dextroamphetamine Sulfate, Dextroamphetamine sulfate 10 mg/1 tablet, listed with the FDA by Cranbury Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dextroamphetamine Sulfate.
What is the active ingredient?: Dextroamphetamine sulfate.
Who is the labeler?: Cranbury Pharmaceuticals, LLC, NDC labeler code 27808. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dextroamphetamine Sulfate?: 38 other product NDCs are listed under this name. See all Dextroamphetamine Sulfate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dextroamphetamine Sulfate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 5 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-089	27808-0089-01
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 2.5 mg/1	TabletOral	Winder Laboratories LLC	75826-120	75826-0120-1075826-0120-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 5 mg/1	TabletOral	Winder Laboratories LLC	75826-121	75826-0121-1075826-0121-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 7.5 mg/1	TabletOral	Winder Laboratories LLC	75826-122	75826-0122-1075826-0122-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 10 mg/1	TabletOral	Winder Laboratories LLC	75826-123	75826-0123-1075826-0123-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 15 mg/1	TabletOral	Winder Laboratories LLC	75826-124	75826-0124-1075826-0124-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 20 mg/1	TabletOral	Winder Laboratories LLC	75826-125	75826-0125-1075826-0125-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 30 mg/1	TabletOral	Winder Laboratories LLC	75826-126	75826-0126-1075826-0126-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 15 mg/1	TabletOral	Wilshire Pharmaceuticals, Inc.	52536-515	52536-0515-03
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 20 mg/1	TabletOral	Wilshire Pharmaceuticals, Inc.	52536-520	52536-0520-03

All 39 Dextroamphetamine Sulfate NDCs

Other NDCs under ANDA 206095

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206095
Product	Strength	Form · route	Labeler	Product NDC
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 5 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-089